Tokushima, Japan

Mitsuo Shimada

This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Corporation, Tokushima University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuo Shimada. Retrieved from https://idiyas.com/inventor/mitsuo-shimada-7rgco7bq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mitsuo Shimada: Innovator in Insulin-Producing Cell Technology

Introduction

Mitsuo Shimada is a prominent inventor based in Tokushima, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of methods for producing insulin-producing cells from mesenchymal stem cells. His innovative work aims to address critical challenges in diabetes treatment.

Latest Patents

Mitsuo Shimada holds a patent for a method for producing insulin-producing cells from mesenchymal stem cells. This patent, which includes 1 patent, outlines a comprehensive approach to creating insulin-producing cells that exhibit sufficient glucose responsiveness. The invention involves a multi-step process that includes incubating biocompatible macromolecular blocks with mesenchymal stem cells and culturing these cells in specific media to enhance their functionality.

Career Highlights

Throughout his career, Mitsuo Shimada has worked with esteemed institutions such as Tokushima University and Fujifilm Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cell technology.

Collaborations

Mitsuo Shimada has collaborated with notable colleagues, including Kentaro Nakamura and Tetsuya Ikemoto. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of scientific knowledge.

Conclusion

Mitsuo Shimada's work in the field of insulin-producing cell technology represents a significant advancement in biotechnology. His innovative methods and collaborations continue to pave the way for future developments in diabetes treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…